[Post-examination phase: description and management control of the process].

Prior research has established the importance of quality assurance in diagnostic testing. However, gaps remain in understanding the post-analytical phase's impact on patient outcomes. This phase involves actions after test results are generated. No prior work had resolved how mismanagement here could lead to harm. Existing studies focus more on pre-analytical and analytical steps. This gap motivated the need to explore post-analytical processes in detail. It was already known that communication breakdowns can affect diagnosis. That uncertainty drove the need to define this phase's structure and risks.

The aim is to describe the post-analytical process and its management. This phase involves transforming raw results into validated data. The study addresses how errors in organization and communication affect outcomes. It focuses on the role of medical biologists in result interpretation. The authors propose ways to improve clinician-patient communication. They highlight the risks of poor sample handling and record-keeping. The paper aims to provide actionable quality indicators. It also suggests a model for clinico-biological collaboration.

The authors outline the steps in the post-analytical process. They describe result validation by authorized professionals. The process includes sample storage, disposal, and record archiving. Communication with clinicians is a central focus. The study proposes quality indicators to assess performance. A model clinico-biological contract is suggested as a tool. The approach combines descriptive analysis with practical examples. The authors use existing frameworks to structure their recommendations.

The post-analytical phase involves result validation and interpretation. Medical biologists play a key role in this process. Errors often stem from poor communication and organization. Sample storage and disposal are critical steps. Records archiving is essential for traceability. Quality indicators are proposed to monitor this phase. A clinico-biological contract model is suggested. These findings highlight the need for structured management.

The authors emphasize the importance of structured post-analytical management. They suggest quality indicators to prevent errors. Communication with clinicians is vital for accurate reporting. Medical biologists must interpret results correctly. Sample handling and record archiving require attention. The proposed contract model supports better coordination. These findings trace to the authors' claims on process control. No generalizations beyond the study's scope are made.